<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> is induced under diabetic conditions and causes various forms of tissue damage in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, pancreatic beta-cells have emerged as a putative target of <z:mp ids='MP_0003674'>oxidative stress</z:mp>-induced tissue damage and this seems to explain in part the progressive deterioration of beta-cell function in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>As a step toward clinical trial of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we investigated the possible anti-diabetic effects of probucol, an <z:chebi fb="11" ids="22586">antioxidant</z:chebi> widely used as an anti-hyperlipidemic agent, on preservation of beta-cell function in diabetic C57BL/KsJ-db/db mice </plain></SENT>
<SENT sid="3" pm="."><plain>Probucol-containing diet was given to mice from 6 to 16 weeks of age </plain></SENT>
<SENT sid="4" pm="."><plain>Immunostaining for <z:mp ids='MP_0003674'>oxidative stress</z:mp> markers such as <z:chebi fb="0" ids="32585">4-hydroxy-2-nonenal</z:chebi> (HNE)-modified proteins and <z:chebi fb="4" ids="30413">heme</z:chebi> oxygenase-1 revealed that probucol treatment decreased reactive oxygen species (ROS) in pancreatic islets of diabetic animals </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> is known to enhance <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of beta-cells and to suppress insulin biosynthesis, but probucol treatment led to preservation of beta-cell mass and the insulin content </plain></SENT>
<SENT sid="6" pm="."><plain>According to intraperitoneal <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance tests, the probucol treatment preserved <z:chebi fb="105" ids="17234">glucose</z:chebi>-stimulated insulin secretion and <z:mp ids='MP_0005292'>improved glucose tolerance</z:mp> at 10 and 16 weeks: insulin, 280+/-82 vs. 914+/-238 pmol/l (120 min, at 16 weeks; P&lt;0.05); <z:chebi fb="105" ids="17234">glucose</z:chebi>, 44.6+/-2.4 vs. 35.2+/-2.6 mmol/l (120 min, at 16 weeks; P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, our present observations demonstrate the potential usefulness of probucol for treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>